State WI
Clinical Trials in Wisconsin
Recruiting clinical trials with at least one study location in Wisconsin. Data updated daily from ClinicalTrials.gov.
Top Conditions in Wisconsin
NCT05243966 N/A
Recruiting
Myriad™ Augmented Soft Tissue Reconstruction Registry
Condition
Abdominal Wound Dehiscence
Enrollment
800 pts
Location
United States
Sponsor
Aroa Biosurgery Limited
NCT06985953 N/A
Recruiting
Evaluating the Communication Between Patients and Providers in Cancer Clinics
Condition
Cancer
Enrollment
30 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
NCT06501196 Phase 1
Recruiting
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Highe...
Condition
Leukemia
Enrollment
170 pts
Location
United States
Sponsor
BlossomHill Therapeutics
NCT06999603 Phase 2
Recruiting
Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respira...
Condition
Viral Pneumonia
Enrollment
550 pts
Location
United States, Belgium, France
Sponsor
Synairgen Research Ltd.
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
NCT06110897 N/A
Recruiting
RESISTance Exercise for Depression Trial
Condition
Major Depressive Disorder
Enrollment
200 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT03942653 Phase 2
Recruiting
Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen...
Condition
Salivary Gland Carcinoma
Enrollment
20 pts
Location
United States
Sponsor
Manish Patel
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
NCT06859801 N/A
Recruiting
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Tre...
Condition
Bone Cancer Metastatic
Enrollment
120 pts
Location
United States
Sponsor
Society of Interventional Onco
NCT05546580 Phase 1
Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyr...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
NCT03806283 N/A
Recruiting
Mechanisms of Pregnancy Vascular Adaptations
Condition
Pre-Eclampsia
Enrollment
166 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and ...
Condition
Leukemia, Myeloid, Acute
Enrollment
120 pts
Location
United States, Canada, Germany
Sponsor
OncoVerity, Inc.
NCT07017322 N/A
Recruiting
Non-invasive Cranial Electrical Stimulation for Mealtime Anxiety in Adults With ...
Condition
Eating Disorders
Enrollment
30 pts
Location
United States
Sponsor
Rogers Behavioral Health
NCT05101551 Phase 1
Recruiting
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML ...
Condition
Acute Myeloid Leukemia
Enrollment
34 pts
Location
United States
Sponsor
Norman J. Lacayo
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
NCT05947851 Phase 3
Recruiting
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Secon...
Condition
Leukemia, Lymphocytic, Chronic, B-Cell
Enrollment
735 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals